Innovative drug cooperation

An innovative pharmaceutical enterprise integrating research and development,
production and marketing, with independent research and development as the driving force

Tofacitinib colon-targeting prodrug HNW

Tofacitinib colon-targeting prodrug HNW

ulcerative colitis (UC) is a chronic recurrent disease with mucous bloody stools, abdominal pain and diarrhea as its main clinical manifestations. It is mainly characterized by superficial mucosal ulc...

2024/07/05
1

Contact us

View more

Add: No. 41, Wanliutang Road, Shenhe District, Shenyang City, Liaoning, China
Contact: Ms.Dong      Mobile: +86-13709882332
Contact: Mr.wang     Mobile: +86-13998853283
E_mail: sales-hinewy@hinewy.com

mobile

Copyright(C)2021,Shenyang Hinewy Pharmaceutical Technology Co., Ltd. All Rights Reserved.
Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice  辽ICP备12017171号-1